Insider filing · BBNX
Mark Hopman
Chief Commercial Officer
profile →
Beta Bionics, Inc.
BBNX · Healthcare · 15 filings in 24 months
ticker →
Mark Hopman sold $371K of Beta Bionics (BBNX)
Executed Sep 4 2025, disclosed Sep 8 2025, 4 days later.
Value, as filed
$371K
18,229 sh across 2 lots
Executed
Sep 4 2025
the trade date, as filed
Disclosed
Sep 8 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MHMark Hopman (Chief Commercial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Beta Bionics, Inc. (BBNX). The largest single filing was $665K of BBNX (35,994 sh × $18.46, as filed), executed Sep 9.
The name
BBNXHealthcare · Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to en…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mark Hopman in BBNX
BBNXSALE
Beta Bionics, Inc.
$620K30,779 sh × $20.13
Exec Sep 16
Filed Sep 17 · 4:15 PM ET BBNXSALE Beta Bionics, Inc. $665K
35,994 sh × $18.46
Exec Sep 9
Filed Sep 18 · 7:51 PM ET † BBNXSALE Beta Bionics, Inc. $102K
5,327 sh × $19.11
Exec Sep 2
Filed Sep 3 · 6:15 PM ET BBNXSALE Beta Bionics, Inc. $268K
16,158 sh × $16.61
Exec Aug 19 2025
Filed Aug 20 2025 · 5:30 PM ET